A judge has indicated that he will allow Arrium Group’s liquidator to give expert evidence at an upcoming trial in proceedings against the steel giant’s former directors over its $4 billion collapse, despite his other role as a party in the case.
Lawyers representing Bluescope in an appeal of a Fair Work case copped a scolding by a judge Thursday for sending multiple emails to his chambers “pressuring” his associate to provide dates for a hearing.
Macquarie Bank is challenging a ruling that it pay $330,000 in pecuniary penalties after it was found to have underpaid a group of former financial advisers because of a “defective and deficient” payment system.
Investment house Washington H. Soul Pattinson is fighting a ruling that it owes its former finance director over $1.1 million in damages after the ASX 100-listed firm terminated the executive without notice and failed to pay out entitlements.
IOOF subsidiary Australian Executor Trustees failed to drag law firm Sparke Helmore into a case after it was hit with a $76.6 million judgment over breaches of duty in the sale of a 42,000 hectare timber plantation by collapsed forestry giant Gunns Group.
A Victorian barrister has reached a settlement on the eve of trial in a breach of fiduciary duty lawsuit brought by a former client who lost a court case over a $24.5 million real estate dispute.
Facebook and its subsidiary Instagram are pushing for a competition dispute brought by an Australian social media startup to be heard on their home turf in the state of California.
A Queensland activist group has come up trumps in a drawn-out legal battle against New Acland Coal’s proposed expansion of a coal mine, with the High Court striking down previous lower court rulings giving it the green light.
The Federal Court has delayed a 15-day hearing in a pneumococcal vaccine patent dispute between Merck Sharp & Dohme and Pfizer after the sudden death of a family member of one of Pfizer’s expert witnesses.
A group of women harmed by pelvic mesh devices produced by Johnson & Johnson have accused it of persisting with a “wreckage” of a case in which one of its own doctors admitted the pharmaceutical company knew of the risks posed by the implants at they time they were sold worldwide.